Melasma (Chlosma) - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 27 pages report, published by Global Markets Direct

Report ThumbnailMay-2017
Melasma (Chlosma) - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melasma (Chlosma) - Pipeline Review, H1 2017, provides an overview of the Melasma (Chlosma) (Dermatology) pipeline landscape.

Melasma is a common skin problem. The condition causes dark, discolored patches on your skin. The dark patches in melasma could be triggered by several factors, including pregnancy, birth control pills, hormone replacement therapy (HR

Read More
  • List of Figures
  • Number of Products under Development for Melasma (Chlosma), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products by Targets, H1 2017
  • Number of Products by Stage and Targets, H1 2017
  • Number of Products by Mechanism of Actions, H1 2017
  • Number of Products by Stage and Mechanism of Actions, H1 2017
  • Number of Products by Routes of Administration, H1 2017
  • Number of Products by Stage and Routes of Administration, H1 2017
  • Number of Products by Molecule Ty
Read More
  • List of Tables
  • Number of Products under Development for Melasma (Chlosma), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Products under Development by Companies, H1 2017
  • Number of Products by Stage and Target, H1 2017
  • Number of Products by Stage and Mechanism of Action, H1 2017
  • Number of Products by Stage and Route of Administration, H1 2017
  • Number of Products by Stage and Molecule Type, H1 2017
  • Melasma (Chlosma) - Pipeline by EpiPharm AG, H1 2017
  • Melasma (Chlosma) - Pipelin
Read More
  • Table of Contents
  • List of Tables
  • List of Figures
  • Introduction
  • Global Markets Direct Report Coverage
  • Melasma (Chlosma) - Overview
  • Melasma (Chlosma) - Therapeutics Development
  • Pipeline Overview
  • Pipeline by Companies
  • Products under Development by Companies
  • Melasma (Chlosma) - Therapeutics Assessment
  • Assessment by Target
  • Assessment by Mechanism of Action
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Melasma (Chlosma) - Companies Involved in Therapeutics Development
  • EpiPharm AG
  • Hy
Read More

Please select a license type

Share

Related Products

Global Markets DirectMelasma (Chlosma) - Pipeline Review, H1 2017Product ThumbnailMelasma (Chlosma) - Pipeline Review, H1 2017, Industry ReportProduct #: 797285
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved